50
Participants
Start Date
January 16, 2019
Primary Completion Date
December 20, 2023
Study Completion Date
December 20, 2023
Platelet rich plasma
Patients will have 60ml of blood drawn. Platelet rich plasma will be obtained by placing the blood in the Arteriocyte Magellan device. 0.5ml of Platelet rich plasma will be placed into the uterus at least 48 hours prior to embryo transfer.
Placebo
Patients will have 60ml of blood drawn. 0.5ml of embryo culture media (the placebo) will be placed into the uterus at least 48 hours prior to embryo transfer.
Stanford Fertility and Reproductive Health, Sunnyvale
Stanford University
OTHER